BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19137215)

  • 1. [Responsibilities of the European Chemical Agency under REACH].
    Foth H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1398-407. PubMed ID: 19137215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk assessment and chemical safety under REACH].
    Foth H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1387-97. PubMed ID: 19137214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Legal aspects of the REACH regulation. The control system of the REACH regulation--new approaches in the EU chemical legislation].
    Pache E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1408-16. PubMed ID: 19137216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [REACH--an ambitious project on the path to chemical safety].
    Foth H; Kahl R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1379-80. PubMed ID: 19137212
    [No Abstract]   [Full Text] [Related]  

  • 5. [The REACH legislation: the consumer and environment protection perspective].
    Gundert-Remy U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1426-33. PubMed ID: 19137218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence-based toxicological evaluation of chemicals by group summaries].
    Greim H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1417-25. PubMed ID: 19137217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REACH: the guidance documents of the European Chemicals Agency (ECHA)].
    Lulei M;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1444-52. PubMed ID: 19137220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
    Lilienblum W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olefins and chemical regulation in Europe: REACH.
    Penman M; Banton M; Erler S; Moore N; Semmler K
    Chem Biol Interact; 2015 Nov; 241():59-65. PubMed ID: 25861726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. That which must not, can not be... A reply to the EChA and EDF responses to the REACH analysis of animal use and costs.
    Hartung T; Rovida C
    ALTEX; 2009; 26(4):307-11. PubMed ID: 20957835
    [No Abstract]   [Full Text] [Related]  

  • 12. European experience in chemicals management: integrating science into policy.
    Christensen FM; Eisenreich SJ; Rasmussen K; Sintes JR; Sokull-Kluettgen B; Van de Plassche EJ
    Environ Sci Technol; 2011 Jan; 45(1):80-9. PubMed ID: 20958022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background of REACH in EU regulations on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Task and function of the European Food Safety Authority].
    Heppner C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Sep; 47(9):862-7. PubMed ID: 15378174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Workshop: use of "read-across" for chemical safety assessment under REACH.
    Patlewicz G; Roberts DW; Aptula A; Blackburn K; Hubesch B
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):226-8. PubMed ID: 23266660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safe usage of chemicals in European Union countries].
    Graczyk A; Czerczak S; Barański B
    Med Pr; 2010; 61(3):333-40. PubMed ID: 20677433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory decision-making under uncertainty: are costs proportionate to benefits when restricting dangerous chemicals on European markets?
    Brouwer R; Cauchi J; Verhoeven J
    Regul Toxicol Pharmacol; 2014 Apr; 68(3):438-46. PubMed ID: 24518386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between bioconcentration factor (BCF) data provided by industry to the European Chemicals Agency (ECHA) and data derived from QSAR models.
    Petoumenou MI; Pizzo F; Cester J; Fernández A; Benfenati E
    Environ Res; 2015 Oct; 142():529-34. PubMed ID: 26282223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transparency of chemical risk assessment data under REACH.
    Ingre-Khans E; Ågerstrand M; Beronius A; Rudén C
    Environ Sci Process Impacts; 2016 Dec; 18(12):1508-1518. PubMed ID: 27819710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of toxicological evaluations for dermal exposure performed under two different EU regulatory frameworks.
    Westerholm E; Schenk L
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):51-8. PubMed ID: 24269627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.